Methimazole treatment in Graves' disease: Behaviour of CD5+B lymphocytes and regulatory T cell subsets

European Review for Medical and Pharmacological Sciences

Volumn 2, Issue 1, 1998, Pages 11-19

  Paggi, A ^a   Amoroso, A ^a   Ferri, G M ^a   Mariotti, A ^a   Pellegrino, C ^a   Afeltra, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autoimmune thyroid diseases; Lymphocyte subsets; Thyrostatic drugs

Indexed keywords

CD5 ANTIGEN; LIOTHYRONINE; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMETRY; FEMALE; FLUORESCENCE ANALYSIS; GRAVES DISEASE; HELPER CELL; HUMAN; LIOTHYRONINE BLOOD LEVEL; LYMPHOCYTE COUNT; MALE; PATHOPHYSIOLOGY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ANTIGENS, CD5; ANTITHYROID AGENTS; B-LYMPHOCYTES; FEMALE; GRAVES DISEASE; HUMANS; MALE; METHIMAZOLE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 0032311467     PISSN: 0392291X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)